Immunotherapy Talks with ACIR
by Accelerating Cancer Immunotherapy Research (ACIR)
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1 - 1,000 - Monthly Reach
Unique listeners across all episodes (30 days)
1 - 5,000 - Active Followers
Loyal subscribers who consistently listen
1 - 500
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
#2 - A biomaterial-based vaccine
Jun 2, 2022
23m 46s
#1- Hooked on immunotherapy
May 14, 2021
15m 11s
Teaser
May 13, 2021
1m 01s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 6/2/22 | #2 - A biomaterial-based vaccine | Send a text In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells. GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab. Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/ Support the show Thanks for listening! Let’s stay in touch: Tweet us at @ImmunoTal... | 23m 46s | |
| 5/14/21 | #1- Hooked on immunotherapy | Send a text In this first episode, our co-hosts talk about their background in immunology and what led them to it. GUEST: Ed Fritsch. PhD, presidential fellow at the Dana-Farber, co-author of "Molecular Cloning: A Laboratory Manual", and co-founder of ACIR. Support the show Thanks for listening! Let’s stay in touch: Tweet us at @ImmunoTalks Share our episodes on LinkedIN and Instagram Email us at contact@acir.org | 15m 11s | |
| 5/13/21 | Teaser | Send a text Introducing "Immunotherapy Talks". Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite size pieces to help you stay on top the field. Support the show Thanks for listening! Let’s stay in touch: Tweet us at @ImmunoTalks Share our episodes on LinkedIN and Instagram Email us at contact@acir.org | 1m 01s |
Showing 3 of 3
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.